HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Influence of bariatric surgery on the expression of nesfatin-1 in rats with type 2 diabetes mellitus.

AbstractOBJECTIVE:
Bariatric surgery has been reported to be very effective in the remission of type 2 diabetes mellitus (T2DM). However, the mechanism is still under debate. Nesfatin-1, a recently discovered anorexigenic neuropeptide, was reported to be very important in glucose metabolism and regulating food intake. In this study, the effects of bariatric surgery on the expression and regulation of nesfatin-1 were discussed.
METHODS:
T2DM was induced in SD rats by a diet high in sugar and fat plus a low dose of streptozotocin (STZ) (25 mg/kg) injection. Bariatric surgeries, including Roux-En-Y Gastric Bypass (RYGB) and sleeve gastrectomy (SG), were performed on these rats. Two months after the surgery, the plasma nesfatin-1 level and the expression of nesfatin-1 in different organs of the rats were tested. Next, in vivo administration of nesfatin-1 after surgery was performed to investigate the role of nesfatin-1 in bariatric surgery.
RESULTS:
Both RYGB and SG could reduce the weight of the rats. However, only RYGB had significant effects on the blood glucose level. Neither surgeries seemed to affect the blood concentration of insulin. However, RYGB significantly improved insulin sensitivity. Expression of nesfatin-1 in the plasma and relative organs decreased in T2DM rats and rose again after RYGB; however, this pattern did not occur in SG. Injection of nesfatin-1 after SG significantly improved insulin resistance and reduced blood glucose levels.
CONCLUSIONS:
Nesfatin-1 may improve insulin sensitivity in T2DM rats and thus plays a very important role in the remission of T2DM after RYGB. This neuropeptide could be a new target for directing future improvements in the bariatric surgical process.
AuthorsZefeng Xia, Geng Wang, Huiqing Li, Chaojie Hu, Qingbo Wang, Anshu Li, Ende Zhao, Xiaoming Shuai, Jiliang Wang, Kailin Cai, Kaixiong Tao, Guobin Wang
JournalCurrent pharmaceutical design (Curr Pharm Des) Vol. 21 Issue 11 Pg. 1464-71 ( 2015) ISSN: 1873-4286 [Electronic] United Arab Emirates
PMID25524371 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Blood Glucose
  • Calcium-Binding Proteins
  • DNA-Binding Proteins
  • Nerve Tissue Proteins
  • Nucb1 protein, rat
  • Nucleobindins
  • Streptozocin
Topics
  • Animals
  • Blood Glucose
  • Calcium-Binding Proteins (administration & dosage, blood, metabolism)
  • DNA-Binding Proteins (administration & dosage, blood, metabolism)
  • Diabetes Mellitus, Experimental (surgery)
  • Diabetes Mellitus, Type 2 (surgery)
  • Gastrectomy (methods)
  • Gastric Bypass (methods)
  • Insulin Resistance (physiology)
  • Male
  • Nerve Tissue Proteins (administration & dosage, blood, metabolism)
  • Nucleobindins
  • Rats
  • Rats, Sprague-Dawley
  • Streptozocin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: